Beijing Institute of Biological Products Co Ltd.
Beijing Institute of Biological Products Co Ltd.
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BSY001 After Single/Multiple Doses. | DNA Virus Infections, Infections, cowpox, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, smallpox, viral infectious disease | Recruiting | Phase 1 | 2026-01-29 | NCT07377175 | |
| A Phase 3 Study of BIBP Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Clostridium infectious disease, Corynebacterium Infections, Infections, bacterial infectious disease, bordetellosis, diphtheria, gram-negative bacterial infections, gram-positive bacterial infections, pertussis, respiratory system disorder, respiratory tract infectious disorder, tetanus | Active, not recruiting | Phase 3 | 2025-09-15 | NCT05091619 |